Loading…
Oragenics, Inc. is projected to rise to $0.5821 by 2027, a +10% move from its current price of $0.5293. OGEN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.5159 | $0.5294 | $0.5433 | +0.02% |
| Aug 6 | $0.5105 | $0.5295 | $0.5493 | +0.04% |
| Aug 7 | $0.5064 | $0.5296 | $0.5539 | +0.06% |
| Aug 8 | $0.503 | $0.5297 | $0.5579 | +0.08% |
| Aug 9 | $0.50 | $0.5298 | $0.5614 | +0.10% |
| Aug 10 | $0.4973 | $0.5299 | $0.5647 | +0.12% |
| Aug 11 | $0.4949 | $0.53 | $0.5676 | +0.14% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.4949 | $0.53 | $0.5676 | +0.14% |
| Week 2 | $0.4817 | $0.5308 | $0.5848 | +0.28% |
| Week 3 | $0.472 | $0.5315 | $0.5985 | +0.42% |
| Week 4 | $0.464 | $0.5322 | $0.6105 | +0.56% |
| Week 5 | $0.4572 | $0.533 | $0.6213 | +0.69% |
| Week 6 | $0.4512 | $0.5337 | $0.6313 | +0.83% |
| Week 7 | $0.4458 | $0.5345 | $0.6408 | +0.97% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Oragenics, Inc. is a development-stage healthcare company focused on the research and development of nasal delivery pharmaceutical therapies for neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification for the treatment of mild traumatic brain injury.
Oragenics, Inc. was incorporated in 1996 and is headquartered in Lakewood Ranch, Florida. The company was formerly known as Oragen, Inc.
Oragenics, Inc. currently trades with a price of $0.501 and a market capitalization of $2.26M. Its market rank stands at 5238.
The near-term forecast for 2026 shows a min price of $0.50, an avg of $0.501, and a max of $0.63 with a neutral sentiment and 0% ROI. This implies a very tight band around the current level in the immediate horizon.
Looking further out, the forecast projects gradual gains, with 2027 avg $0.5595 and 2028 avg $0.5773, while 2032 avg $0.6047 and max $0.9041 with a 20.7% ROI and bullish sentiment. By 2050 the avg is $1.39 and the max $2.53, delivering a 178.3% ROI with bullish sentiment.
A major floor 21.9% below — a decisive break under it would weaken the trend.
The nearest floor, 7.4% below — buyers have tended to step in here.
The nearest ceiling, 15.2% above — a clean break opens room to run.
A major ceiling 36.0% above — clearing it would confirm fresh momentum.
Key OGEN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OGEN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.498 | Buy | $0.501 | Buy |
| MA 10 | $0.512 | Buy | $0.5131 | Buy |
| MA 20 | $0.542 | Sell | $0.5336 | Sell |
| MA 50 | $0.5746 | Sell | $0.5695 | Sell |
| MA 100 | $0.614 | Sell | $0.6526 | Sell |
| MA 200 | $0.7764 | Sell | $1.64 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 31.80 | Neutral |
| Stoch RSI (14) | 30.96 | Neutral |
| CCI (20) | -93.33 | Neutral |
| Williams %R (14) | -87.50 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -10.71 | Sell |
| Bollinger %B (20,2) | 0.19 | Neutral |
| Stochastic %K (14) | 12.50 | Buy |
| TRIX (15) | -0.50 | Sell |
| Awesome (5,34) | -0.06 | Sell |
| Ultimate (7,14,28) | 19.71 | Buy |
| Momentum (10) | -0.05 | Sell |
| Aroon Osc (25) | -80.00 | Sell |
| Hull MA (9) | 0.49 | Buy |
| ADX (14) | 24.95 | Sell |
| ATR (14) | 0.01 | Info |
The 30-day technical picture is neutral. RSI14 is 30, and the short-term trend is not strongly tilted in either direction.
SMA50 is $0.5808 and SMA200 is $0.7933, indicating price action below the longer-term average but near-term support around the $0.50 level.
The stock shows a 30-day range from $0.4222 to $0.5944, with support at $0.50 and resistance at $0.62. Annualized volatility is indicated at 50, underscoring notable near-term fluctuation potential.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.49 | $0.5293 | $0.6675 | 0% | Neutral | |
| $0.4665 | $0.5821 | $0.7665 | +10% | Neutral | |
| $0.4691 | $0.6012 | $0.8206 | +14% | Neutral | |
| $0.4234 | $0.5547 | $0.7787 | +5% | Neutral | |
| $0.4163 | $0.5561 | $0.7993 | +5% | Neutral | |
| $0.4129 | $0.5614 | $0.8236 | +6% | Neutral | |
| $0.4646 | $0.642 | $0.9595 | +21% | Bullish | |
| $0.5254 | $0.7373 | $1.12 | +39% | Bullish | |
| $0.5013 | $0.7137 | $1.10 | +35% | Bullish | |
| $0.4803 | $0.6933 | $1.09 | +31% | Bullish | |
| $0.6248 | $0.9602 | $1.60 | +81% | Bullish | |
| $0.8698 | $1.49 | $2.70 | +181% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.49 | $0.5293 | $0.6332 | +0.00% |
| September 2026 | $0.4434 | $0.5234 | $0.6347 | -1.11% |
| October 2026 | $0.4535 | $0.5389 | $0.6602 | +2.96% |
| November 2026 | $0.4599 | $0.5494 | $0.6787 | +1.95% |
| December 2026 | $0.4468 | $0.5364 | $0.6675 | -2.37% |
Click any year to see its month-by-month OGEN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Oragenics, Inc.'s 2026 outlook centres on $0.5293, within a $0.49 to $0.6675 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, OGEN could reach as high as $0.7665, with a base case around $0.5821 and support toward $0.4665 — roughly +10% from $0.5293. A consolidation phase looks the most probable path here.
Expect OGEN to range from $0.4691 to $0.8206 through 2028. The $0.6012 average target implies a +14% move from current prices. That is up +3% on the projected 2027 average. Price action looks broadly range-bound.
The OGEN price prediction for 2029 points to an average of $0.5547 (low $0.4234, high $0.7787) — a potential gain of +5% on today's $0.5293. A consolidation phase looks the most probable path here.
In 2030, OGEN is projected to trade between $0.4163 and $0.7993, averaging $0.5561 — a potential gain of +5% from today's $0.5293. That is up 0% on the projected 2029 average. Price action looks broadly range-bound.
Oragenics, Inc.'s 2031 outlook centres on $0.5614, within a $0.4129 to $0.8236 range. That is up +1% on the projected 2030 average. That marks a +6% change versus current levels. A consolidation phase looks the most probable path here.
By 2032, OGEN could reach as high as $0.9595, with a base case around $0.642 and support toward $0.4646 — roughly +21% from $0.5293. Momentum favours further upside here.
Expect OGEN to range from $0.5254 to $1.12 through 2033. The $0.7373 average target implies a +39% move from current prices. That is up +15% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The OGEN price prediction for 2034 points to an average of $0.7137 (low $0.5013, high $1.10) — a potential gain of +35% on today's $0.5293. Momentum favours further upside here.
In 2035, OGEN is projected to trade between $0.4803 and $1.09, averaging $0.6933 — a potential gain of +31% from today's $0.5293. That is -3% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
Oragenics, Inc.'s 2040 outlook centres on $0.9602, within a $0.6248 to $1.60 range. That is up +38% on the projected 2035 average. That marks a +81% change versus current levels. Momentum favours further upside here.
By 2050, OGEN could reach as high as $2.70, with a base case around $1.49 and support toward $0.8698 — roughly +181% from $0.5293. Buyers look set to stay in control over this stretch.
Investing $1,000 in OGEN today (≈ 1,889.287739 OGEN) could be worth
$2,811.43
+$1,811.43 (+181%) by 2050 · US Dollar
Based on the average projected OGEN price of $1.49 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OGENwould be worth at today's price.
$1,000 invested in OGEN on Jul 31, 2025 (≈ 793.6508 OGEN) would be worth
$420.08
-$579.92 (-58.0%) today · 0.42× · US Dollar
Based on a OGEN entry price of $1.26 vs. today's $0.5293.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.51 | $1,037.84 | +3.8% |
| 1 month ago | $0.61 | $867.7 | -13.2% |
| 3 months ago | $0.62 | $853.71 | -14.6% |
| 6 months ago | $0.84 | $630.12 | -37.0% |
| 1 year ago | $1.26 | $420.08 | -58.0% |
| All time (5.0y) ago | $1,332 | $0.4 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OGEN forecast.
Our base-case forecast reaches $1.10 around 2050.
Implied market cap at $1.10: $4.96M
The multi-year forecast lays out an evolving path from today toward higher price levels with several milestones highlighted. In 2030, the avg price is projected at $0.5339 with a max of $0.7679 and a 6.6% ROI, while sentiment remains NEUTRAL. The forecast pivots more decisively bullish from 2032 onward, with 2032 avg $0.6047, max $0.9041 and 20.7% ROI; 2033 avg $0.7071, max $1.08 and 41.1% ROI.
Further gains appear in 2040 (avg $0.9143, max $1.52, ROI 82.5%) and culminate by 2050 (avg $1.39, max $2.53, ROI 178.3%), with bullish sentiment continuing through those years. These figures reflect a high-variance, growth-oriented trajectory rather than a guaranteed outcome, and volatility remains a meaningful factor (annualized volatility 50). Such forecasts are estimates, not guarantees, and are subject to market and company-specific risks.
Tap a question to reveal the answer.
2026 min $0.50, avg $0.501, max $0.63; 2030 min $0.3995, avg $0.5339, max $0.7679; ROI 6.6%; sentiment NEUTRAL.
Forecasts show NEUTRAL sentiment through 2031, followed by BULLISH sentiment from 2032 onward. 2032 avg $0.6047 (ROI 20.7%), 2040 avg $0.9143 (ROI 82.5%), and 2050 avg $1.39 (ROI 178.3%). These are estimates, not guarantees.
2040 avg $0.9143, max $1.52, min $0.5945, ROI 82.5%, sentiment BULLISH.
Current price $0.501; market cap $2.26M; rank 5238.
RSI14 30, SMA50 $0.5808, SMA200 $0.7933, support $0.50, resistance $0.62, 30-day range $0.4222–$0.5944; sentiment NEUTRAL; annualized volatility 50.
Oragenics, Inc. Community Discussion
0Share your Oragenics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.